Drugs / Jianpi Lishi Jiedu Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07505056 | May → Dec 2026 expected | colorectal adenoma | Nanjing First Hospital, Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jianpi Lishi Jiedu Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07505056 ↗ |
| Route | Oral | “orally administered” NCT07505056 ↗ |